Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 randomized double-blind placebo-controlled SAD/MAD/food-effect study of THB001 in healthy adults
NL-OMON50828Phase 1Active, not recruiting
- Sponsor
- Third Harmonic Bio
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in allergy comparing THB001 with Placebo (2 arms). Primary endpoint: Safety and tolerability. Started Mar 2021; status: active, not recruiting.
02
Drugs
THB001
03
Conditions
allergy
Beyond the preview
Go deeper on NL-OMON50828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50828.